
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 12 | 2399.25 | 2403.35 | 14 |
| 8 | 2399.20 | 2403.40 | 4 |
| 18 | 2399.15 | 2403.45 | 8 |
| 13 | 2399.10 | 2403.55 | 13 |
| 13 | 2399.00 | 2403.70 | 4 |
| 17185 | Total | Total | 16668 |
As on 28 Jul, 2023 | 11:00
| BUY | SELL | ||
|---|---|---|---|
| QTY | PRICE | PRICE | QTY |
| 12 | 2399.25 | 2403.35 | 14 |
| 8 | 2399.20 | 2403.40 | 4 |
| 18 | 2399.15 | 2403.45 | 8 |
| 13 | 2399.10 | 2403.55 | 13 |
| 13 | 2399.00 | 2403.70 | 4 |
| 17185 | Total | Total | 16668 |
As on --
(OI , PRICE )
As on --
Stock with good financial performance alongside good to expensive valuation
| Open | 2,494.40 |
| Previous Close | 2,481.95 |
| Volume | 345,275.00 |
| Value (Lacs) | 8,366.01 |
| VWAP | 2,406.24 |
| Beta |
| High | 2,494.40 |
| Low | 2,368.00 |
| UC Limit | 2,730.10 |
| LC Limit | 2,233.75 |
| 52 Week High | 2,750.00 |
| 52 Week Low | 1,762.05 |
| TTM EPS See historical trend | 28.64 (-11.96% YoY) |
| TTM PE See historical trend | 84.60 (High PE) |
| P/B See historical trend | 13.95 (Average P/B) |
| Face Value | 10.00 |
| Mkt Cap (Rs. Cr.) | 20,211 |
| Dividend Yield | 0.50 |
| 20D Avg Volume | 272,248 |
| 20D Avg Delivery(%) | 36.56 |
| Sector PE | 69.53 |
| Book Value Per Share | 173.81 |
*Delayed by 20 seconds.
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the day, calculated based on price range of the previous trading day.
| Days | |
|---|---|
| 5 | - - |
| 10 | - - |
| 20 | - - |
| 50 | - - |
| 100 | - - |
| 200 | - - |
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the week, calculated based on price range of the previous trading week.
| Days |
|---|
| Type | R1 | R2 | R3 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | - - | - - | - - | - - | - - | - - | - - |
| Fibonacci | - - | - - | - - | - - | - - | - - | - - |
| Camarilla | - - | - - | - - | - - | - - | - - | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| R1 | - - | Pivot - - |
S1 | - - |
| R2 | - - | S2 | - - | |
| R3 | - - | S3 | - - |
Note : Support and Resistance level for the month, calculated based on price range of the previous trading month.
| Days |
|---|
| 1 Week | --% | |
| 1 Month | --% | |
| 3 Months | --% | |
| YTD | --% | |
| 1 Year | --% | |
| 3 Years | --% |
Trade Spotlight | Your strategy for M&M Financial Services, eClerx Services, Dr Lal PathLabs Jun 20 2023 06:06 AM
Top 10 trading ideas for next 3-4 weeks as Nifty may scale higher despite consolidation May 15 2023 09:05 AM
Dr Lal PathLab Consolidated March 2023 Net Sales at Rs 491.00 crore, up 1.13% Y-o-Y May 12 2023 10:05 AM
Dr Lal PathLabs stock under pressure after March quarter earnings fails to impress May 12 2023 09:05 AM
| Qty 69319 | Price 2550.9 | % Traded 0.08 |
| Qty 12949 | Price 2550.9 | % Traded 0.02 |
| Qty 69319 | Price 2550.9 | % Traded 0.08 |
| Qty 12949 | Price 2550.9 | % Traded 0.02 |
| Qty 69250 | Price 2377.5 | % Traded 0.08 |
| Qty 12934 | Price 2377.5 | % Traded 0.02 |
| Qty 69250 | Price 2377.5 | % Traded 0.08 |
| Qty 12934 | Price 2377.5 | % Traded 0.02 |
*Transaction of a minimum quantity of 500,000 shares or a minimum value of Rs 5 crore.
| Qty 422494 | Price 840 | % Traded 0.51 |
| Qty 1200000 | Price 780.72 | % Traded 1.44 |
| Qty 900000 | Price 780.26 | % Traded 1.08 |
| Qty 550100 | Price 950.02 | % Traded 0.66 |
| Qty 1291920 | Price 950.27 | % Traded 1.55 |
| Qty 1225260 | Price 1000.38 | % Traded 1.47 |
| Qty 447966 | Price 877.66 | % Traded 0.54 |
| Qty 447966 | Price 877.99 | % Traded 0.54 |
*A bulk deal is a trade where total quantity of shares bought or sold is more than 0.5% of the equity shares of a company listed on the exchange.
| Qty 6000 | Price 311.3 | % Traded 0.01 | Post Tnx Hold. 0.03% |
| Qty 2000 | Price 2269.51 | % Traded 0.00 | Post Tnx Hold. 0.02% |
| Qty 4000 | Price 2275.01 | % Traded 0.00 | Post Tnx Hold. 0.02% |
| Qty 3000 | Price 2210.09 | % Traded 0.00 | Post Tnx Hold. 0.02% |
| Qty 600 | Price 10 | % Traded 0.00 | Post Tnx Hold. 0.44% |
| Qty 16613 | Price 2219.03 | % Traded 0.02 | Post Tnx Hold. 1.28% |
*Disclosures under SEBI Prohibition of Insider Trading Regulations, 2015
| Qty 1670378 | Price 0 | % Traded 2.00 | Post Tnx Hold. 7.04% |
*Disclosures under SEBI SAST (Substantial Acquisition of Shares and Takeovers) Regulations, 2011
| Date | Agenda |
|---|
| Ex-Date | Type | Dividend (Rs) |
|---|
| Announcement Date | Ex-Bonus | Ratio |
|---|
| Ex-Split | Old FV | New FV |
|---|
| Ex-Right | Ratio | Premium |
|---|
| Date | Agenda |
|---|
| Company Name | Price | % Chg | MCap(Cr) | TTM PE | P/B | ROE(%) | 1 Yr Perform(%) | Net Profit(Rs.) | Net Sales(Rs.) | Debt to Equity |
|---|---|---|---|---|---|---|---|---|---|---|
| Dr Lal PathLab | 2,397.75 | -3.39 | 20,000.80 | 83.72 | 12.95 | 14.33 | 11.81 | 241 | 2,016 | 0.14 |
| Apollo Hospital | 5,231.80 | 0.31 | 75,225.26 | 91.83 | 12.75 | 13.21 | 24.85 | 887 | 16,612 | 0.44 |
| Max Healthcare | 607.15 | 0.70 | 58,979.60 | 53.45 | 9.37 | 14.89 | 67.24 | 1,103 | 4,562 | 0.09 |
| Fortis Health | 334.20 | -0.76 | 25,230.70 | 42.85 | 3.60 | 8.12 | 20.78 | 611 | 6,297 | 0.10 |
| Narayana Hruda | 1,053.50 | 0.39 | 21,529.41 | 35.51 | 14.46 | 28.44 | 59.92 | 606 | 4,524 | 0.36 |
Your feedback matters! Tell us what we got right and what we didn’t? Click here>